CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205473709
- Phone
- 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- 4 Open-market buy CEO and CFO bought 1,000 shares at $13.84 ($13,840)
- 4 Open-market buy VP Clinical Reg Affairs bought 250 shares at $13.98 ($3,495)
- 4 Open-market buy CEO and CFO bought 2,000 shares at $8.79 ($17,580)
- 4 Open-market buy CEO and CFO bought 3,000 shares at $9.75 ($29,250)
- 4 Open-market buy CEO and CFO bought 2,000 shares at $9.72 ($19,440)
- 4 Open-market buy CEO and CFO bought 1,000 shares at $9.46 ($9,460)
- 4 Open-market buy CEO and CFO bought 1,000 shares at $9.23 ($9,230)
- 4 Open-market buy CEO and CFO bought 29,000 shares at $9.13 ($264,770)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO and CFO bought 8,000 shares at $7.13 ($57,040)
- 4 Open-market buy CEO and CFO bought 12,000 shares at $7.91 ($94,920)
- 4 Open-market buy CEO and CFO bought 12,000 shares at $8.33 ($99,960)
- 4 Open-market buy CEO and CFO bought 4,500 shares at $10.90 ($49,050)
- 4 Open-market buy CEO and CFO bought 6,000 shares at $8.55 ($51,300)
- 4 Open-market buy CEO and CFO bought 9,250 shares at $8.35 ($77,238)
Page 5 of 8 · 146 filings